Back to search
FDAFDA · Food and drugs·Recall number D-0399-2015

Atracurium Besylate Injection, USP, 100 mg per 10 mL (10 mg per mL), Rx Only, 10 mL Multi-Dose Vial, For Intravenous Injection, Mfd. for: Sagent Pharmaceuticals, Schaumberg, IL 60195, NDC 25021-672-10

Published March 11, 2015 · Recall initiated: February 23, 2015

Summary

FDA records drug Class II recall D-0399-2015, published March 11, 2015 and initiated February 23, 2015. Recalling firm: Sagent Pharmaceuticals Inc; Status: Terminated; Reported quantity: 140,850 vials; Lot: Lot Numbers: VATB012, VATB013, VATB014, Exp 11/15; VATB017, Exp 08/16. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Lack of Assurance of Sterility: Recall initiated due to FDA observations pertaining to aseptic and GMP practices at the manufacturers site potentially impacting product sterility.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Sagent Pharmaceuticals Inc
Distributor
Nationwide and Puerto Rico
Lot
Lot Numbers: VATB012, VATB013, VATB014, Exp 11/15; VATB017, Exp 08/16
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Atracurium Besylate Injection, USP, 100 mg per 10 mL (10 mg per mL), Rx Only, 10 mL Multi-Dose Vial, For Intravenous Injection, Mfd. for: Sagent Pharmaceuticals, Schaumberg, IL 60195, NDC 25021-672-10 recalled?

Yes. FDA published recall D-0399-2015 on March 11, 2015. Reported hazard: Lack of Assurance of Sterility: Recall initiated due to FDA observations pertaining to aseptic and GMP practices at the manufacturers site potentially impacting product sterility.

What should I do if I have this product?

Voluntary: Firm initiated · Letter